Cryosurgery is the application of
extremely low temperature to destroy abnormal tissue. The technique has
been successful in treating some types of cancer and skin disease.
Extreme low temperature for cryosurgery is achieved by using liquid
nitrogen or argon gas. For treatment of external conditions, liquid
nitrogen is applied to the diseased skin cells with the help of a cotton
swab or spraying device. To treat internal conditions, liquid nitrogen
or argon gas is passed through hollow probes, which are efficiently
guided by MRI or ultrasound. Cryosurgery has been successfully applied
for treating cancers such as retinoblastoma, basal cell and squamous
cell carcinoma, and cervical cancer. The technique is also used for
treating cervical dysplasia.
Cryosurgery is a minimally invasive
procedure. Increasing prevalence of cancer in developing countries is
likely to drive the growth of the cryosurgery equipment market.
Moreover, as the application is localized and restricted to abnormal
tissues, healthy tissue is maintained and side-effects are reduced.
Cryosurgery treatment can also be used in combination with other methods
such as hormone therapy, radiation and chemotherapy leading to the
reduction in use of drugs causing harmful side effects. Cry-Ac,
Cryoalfa, CryoClear, CryoPen, Verruca-Freeze, Premier CryOmega, and
CryoProbe are examples of cryosurgery products.
According to World Health Organization,
cervical cancer is the fourth most common cancer in women, and the
seventh overall, with an estimated 528,000 new cases in 2012. There were
an estimated 266,000 deaths from cervical cancer worldwide in 2012,
accounting for 7.5% of all female cancer deaths. Almost nine out of ten
(87%) cervical cancer deaths occur in less developed regions. According
to Centers for Disease Control and Prevention (CDC), in 2014, 12,578
women in the United States were diagnosed with cervical cancer and 4,115
women in the country died from this cancer.
The cryosurgery equipment market is
segmented by product type, application, end user, and geography. Based
on products, the market is segmented into systems and consumables. Based
on application, the market is segmented into cancer, skin tags, skin
tumors and others. Based on end user, the market is segmented into
hospitals, clinics, diagnostic centers and others.
Geographically, the cryosurgery equipment
market has been categorized into five regions, North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North America
is expected to be the dominant market in terms of revenue due to
increasing demand for minimally invasive procedures and technologically
advanced products. Europe is expected to be the second largest market
owing to increasing prevalence of cancer. According to the World Health
Organization, 1 in 25,000 women die from cervical cancer in the WHO
European Region. It remains the second most common cancer among women
aged 15-44. The market in Asia Pacific is expected to expand at the
highest CAGR during the forecast period due to increasing prevalence of
cancer in the region. According to National Center for Biotechnology
Information, every year in India, 122,844 women are diagnosed with
cervical cancer and 67,477 die from the disease. India has a population
of 432.2 million women aged 15 years and older who are at risk of
developing cancer. The Latin America cryosurgery equipment market is
expected to grow due to increasing demand for minimally invasive
procedures. The Middle East & Africa region is expected to witness
growth due to increasing disposable income and establishment/expansion
of Western companies (North America and Europe) in the regions.
Major players operating in the
cryosurgery equipment market include Brymill Cryogenic Systems, Cortex
Technology ApS, Wallach Surgical Devices, CryoSurgery, Inc., CryoIQ AB,
Cryoswiss GmbH, Medtronic, CryoConcepts LP, and Zimmer MedizinSystems
among others
No comments:
Post a Comment